Canadian COVID-19 host genetics cohort replicates known severity associations.


Journal

PLoS genetics
ISSN: 1553-7404
Titre abrégé: PLoS Genet
Pays: United States
ID NLM: 101239074

Informations de publication

Date de publication:
22 Mar 2024
Historique:
received: 30 06 2023
accepted: 22 02 2024
medline: 22 3 2024
pubmed: 22 3 2024
entrez: 22 3 2024
Statut: aheadofprint

Résumé

The HostSeq initiative recruited 10,059 Canadians infected with SARS-CoV-2 between March 2020 and March 2023, obtained clinical information on their disease experience and whole genome sequenced (WGS) their DNA. We analyzed the WGS data for genetic contributors to severe COVID-19 (considering 3,499 hospitalized cases and 4,975 non-hospitalized after quality control). We investigated the evidence for replication of loci reported by the International Host Genetics Initiative (HGI); analyzed the X chromosome; conducted rare variant gene-based analysis and polygenic risk score testing. Population stratification was adjusted for using meta-analysis across ancestry groups. We replicated two loci identified by the HGI for COVID-19 severity: the LZTFL1/SLC6A20 locus on chromosome 3 and the FOXP4 locus on chromosome 6 (the latter with a variant significant at P < 5E-8). We found novel significant associations with MRAS and WDR89 in gene-based analyses, and constructed a polygenic risk score that explained 1.01% of the variance in severe COVID-19. This study provides independent evidence confirming the robustness of previously identified COVID-19 severity loci by the HGI and identifies novel genes for further investigation.

Identifiants

pubmed: 38517939
doi: 10.1371/journal.pgen.1011192
pii: PGENETICS-D-23-00732
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1011192

Informations de copyright

Copyright: © 2024 Garg et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Elika Garg (E)

Department of Statistics and Actuarial Science, Simon Fraser University, Vancouver, British Columbia, Canada.
Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.

Paola Arguello-Pascualli (P)

BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.
Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada.

Olga Vishnyakova (O)

Department of Statistics and Actuarial Science, Simon Fraser University, Vancouver, British Columbia, Canada.
Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, British Columbia, Canada.

Anat R Halevy (AR)

Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.

Samantha Yoo (S)

Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.

Jennifer D Brooks (JD)

Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.

Shelley B Bull (SB)

Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Lunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto, Ontario, Canada.

France Gagnon (F)

Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.

Celia M T Greenwood (CMT)

Gerald Bronfman Department of Oncology, Department of Epidemiology, Biostatistics and Occupational Health, Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.

Rayjean J Hung (RJ)

Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Lunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto, Ontario, Canada.

Jerald F Lawless (JF)

Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, Ontario, Canada.

Jordan Lerner-Ellis (J)

Lunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto, Ontario, Canada.
Mount Sinai Hospital, Toronto, Ontario, Canada.
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.

Jessica K Dennis (JK)

BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.
Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada.

Rohan J S Abraham (RJS)

Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, British Columbia, Canada.

Jean-Michel Garant (JM)

Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, British Columbia, Canada.

Bhooma Thiruvahindrapuram (B)

Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.

Steven J M Jones (SJM)

Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, British Columbia, Canada.
Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada.

Lisa J Strug (LJ)

Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Department of Statistical Sciences, University of Toronto, Toronto, Ontario, Canada.

Andrew D Paterson (AD)

Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.

Lei Sun (L)

Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Department of Statistical Sciences, University of Toronto, Toronto, Ontario, Canada.

Lloyd T Elliott (LT)

Department of Statistics and Actuarial Science, Simon Fraser University, Vancouver, British Columbia, Canada.

Classifications MeSH